Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
This NA trial investigates Hypoxemia and Obstructive Sleep Apnea and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Mar 2019 [monthly]
Completed NA
-
Jul 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Jul 2017 [monthly]
Completed NA
First recorded
Apr 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • New York, United States